Search
for
Sort by
Research 901–930 of 1000+
- PCPT Results Could Affect Trial on Testosterone Replacement
- Australian Hair and Wool Research Society Cutaneous Biology and Endocrinology Workshop
- Impact of baseline PSA level on quality of life measures of general health and sexual satisfaction/drive in men with BPH treated with finasteride or placebo
- Androstenedione
- 17α-Acetoxy-6-bromo-16β-methylpregna-4,6-diene-3,20-dione
- 187 Protective Effect of DA-9401 on Acute use of Finasteride on Sprague–Dawley Rats
- PD02-05 SRD5A2 EXPRESSION IS A PREDICTOR OF RESPONSE TO FINASTERIDE IN THE MTOPS TRIAL
- Synthesis, Characterization and Evaluation of 5α, 6β-Dihalo Androsterone Derivatives as 5α-Reductase Inhibitors
- How to Deal with the Issues of Fertility, Malignancies, and the Postfinasteride Syndrome while Prescribing Finasteride for Male Pattern Hair Loss
- Androgenetic Alopecia From A to Z
- Modulation der Hitzesensitivität im Prostatakarzinom in vitro: Der Einfluss der Androgenachse
- A Retrospective Study of Semen Quality in Young Infertile Men with Androgenetic Alopecia after Discontinuation of Finasteride
- One year cross-sectional study of association between androgenetic alopecia and benign prostatic hyperplasia in a tertiary care hospital
- Post-Finasteride Syndrome (PFS) Update: Point/Counterpoint
- Bernstein’s Consent and Information on Finasteride and Propecia®
- Finasteride
- PD16-01 NEW INSIGHT OF PSA REDUCTION DURING FINASTERIDE THERAPY
- 1748 IS ANDROGENETIC ALOPECIA ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA? ANALYSIS OF 907 PATIENTS
- Faculty Opinions recommendation of Six novel susceptibility Loci for early-onset androgenetic alopecia and their unexpected association with common diseases.
- Faculty Opinions recommendation of Androgenetic alopecia as an early marker of benign prostatic hyperplasia.
- Faculty Opinions recommendation of Androgenetic alopecia as an early marker of benign prostatic hyperplasia.
- Comorbidities in patients with androgenetic alopecia: cardiovascular risk factors and benign prostatic hyperplasia
- Age-related changes in brain and pituitary 5α-reductase with finasteride (Proscar) treatment
- Comparative Study of Therapeutic Effect of Dibenyline, Finasteride, and Combination Drugs for Symptomatic Benign Prostatic Hyperplasia
- Molecular Interactions of New Pregnenedione Derivatives
- Synthesis and biological evaluation of novel unsaturated carboxysteroids as human 5α-reductase inhibitors: A legitimate approach
- FCE 28260, a new 5α-reductase inhibitor: In vitro and in vivo effects
- The beneficial effects of Pumpkin (<i>Cucurbita pepo</i>L.) seed oil for health condition of men
- 5α-Reductase Inhibitors (5ARIs) and Male Reproduction
- Efficacy and safety of Finasteride (5 alpha-reductase inhibitor) monotherapy in patients with benign prostatic hyperplasia: A critical review of the literature